Ibrahim Raphiou
AstraZeneca (Australia)(AU)AstraZeneca (Switzerland)(CH)AstraZeneca (Spain)(ES)
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery, Pediatric health and respiratory diseases
Most-Cited Works
- → Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone(2016)155 cited
- → Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma(2016)135 cited
- → Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol(2009)85 cited
- → Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation(2014)48 cited
- → Methylation and expression of the lactoferrin gene in human tissues and cancer cells(2004)41 cited
- → Prevalence of COPD among symptomatic patients in a primary care setting(2009)36 cited
- →